4.7 Article

Dietary flavonoid narirutin as a prospective antagonist of oncogenic pri/pre-microRNAs

期刊

PHYTOTHERAPY RESEARCH
卷 36, 期 2, 页码 963-983

出版社

WILEY
DOI: 10.1002/ptr.7367

关键词

cancer; flavonoids; miRNAs; molecular targets; molecular-simulation; narirutin

资金

  1. Council of Scientific & Industrial Research (CSIR), New Delhi
  2. [CSIR-CIMAP-MLP-11]

向作者/读者索取更多资源

This study identified the flavonoid narirutin as a potential antagonist of miRNAs through molecular docking simulation, which disrupts the synthesis and processing of miRNA and shows potential for cancer prevention and treatment.
MicroRNAs (miRNAs) are involved in cancer progression via translational degradation in a sequence-specific manner of the 3 '-untranslated region (3 ' UTR) of messenger RNA (mRNA). The involvement of miRNA in the biological progression of various cancer types is considered to be a potential target. Primary miRNA (pri-miRNA) and precursor-miRNA (pre-miRNA) synthesize the miRNA by dicer-catalyzed processes thus targeting pri/pre-miRNA by phytochemicals is amongst the appropriate approaches for anticancer therapies. Flavonoids category of phytochemicals is well-known for its chemotherapeutic and chemopreventive potential against multiple cancer types. However, the molecular interactions of flavonoids with miRNAs are not reported so far. Thus, this study aims to identify the promising flavonoids as the antagonist of miRNAs (pre-miR21, pri-miR-208a, pri-miR-378a, pri-miR320b, pri-miR-300, pri-miR-19b, and pre-miR-20b) using molecular docking simulations studies. Among the tested flavonoids, narirutin showed highest binding energy (-11.7 kcal/mol) against pri-miR19b followed by pri-miR-378a (-11.4 kcal/mol) > pri-miR320b (-11.2 kcal/mol) = pri-miR-300 (-11.2 kcal/mol) > pri-miR-208a (-9.0 kcal/mol) > pre-miR-20b (- 8.3 kcal/mol). The molecular dynamic simulation experiment confirmed that narirutin destabilizes the tertiary structure of pri-miRNA in comparison to apo-RNA. The finding indicates that narirutin binding with pre-miRNA causes disruption of pri-RNA structure that creates a loss of DICER-pre-miRNA interactions by hindering the pre-miRNA synthesis, thereby affecting miRNA processing. Further pharmacokinetics and toxicity prediction revealed that it is non-carcinogenic, non-mutagenic, and does not inhibit the CYPs activity. Thus, narirutin could be a possible antagonist of oncogenic miRNAs, therefore could be useful for miRNA-targeted cancer prevention and treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Exploration of Chemopreventive Potential of Linalool in Targeting Lung Cancer Biomarkers

Jyoti Singh, Abha Meena

Summary: This study investigates the targeting efficacy of linalool against biomarkers associated with different stages of lung cancer. In silico molecular docking analysis and cytotoxicity evaluation on A549 cell line revealed that linalool has a strong binding affinity with selected targets and significantly reduces cell viability.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2022)

Review Chemistry, Medicinal

Promising Essential Oils/Plant Extracts in the Prevention and Treatment of Dandruff Pathogenesis

K. M. Uma Kumari, Narayan Prasad Yadav, Suaib Luqman

Summary: This review focuses on the occurrence and etiology of dandruff, as well as the potential application of plant essential oils/extracts and novel treatment strategies. Current findings suggest that topical antifungals are the first line of treatment, but they have specific side effects. Alternative therapies, such as tea tree oil, thyme, and Aloe vera, have shown anti-dandruff activity by disrupting microbial growth.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2022)

Article Environmental Sciences

Escin-sorafenib synergy up-regulates LC3-II and p62 to induce apoptosis in hepatocellular carcinoma cells

Yusuf Hussain, Jyoti Singh, Abha Meena, Rohit Anthony Sinha, Suaib Luqman

Summary: The therapeutic potential of combining escin and sorafenib for liver cancer treatment has been established in this study, and the underlying mechanism involving the up-regulation of p62 to block autophagy and induce late apoptosis in liver cancer cells has been elucidated.

ENVIRONMENTAL TOXICOLOGY (2023)

Article Food Science & Technology

Myricitrin from bayberry as a potential inhibitor of cathepsin-D: Prospects for squamous lung carcinoma prevention

Shilpi Singh, Akhilesh Kumar Maurya, Abha Meena, Nidhi Mishra, Suaib Luqman

Summary: This study investigated the binding affinity of myricitrin to CATD and found a strong affinity. The stability of the complex was confirmed through molecular dynamics simulation, and enzyme activity studies showed inhibitory concentration. The experimental findings suggest that myricitrin could be a potential therapeutic agent for CATD-mediated lung cancer.

FOOD AND CHEMICAL TOXICOLOGY (2023)

Article Biochemistry & Molecular Biology

3,5,7-trihydroxyflavone restricts proliferation of androgen-independent human prostate adenocarcinoma cells by inducing ROS-mediated apoptosis and reduces tumour growth

Waseem Raza, Abha Meena, Suaib Luqman

Summary: This study explores the potential of 3,5,7-trihydroxyflavone (THF) in inhibiting prostate cancer cell growth through reactive oxygen species (ROS) generation and also examines its tumor reduction potential in mice.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2023)

Article Biochemistry & Molecular Biology

Dalbergia sissoo phytochemicals as EGFR inhibitors: an in vitro and in silico approach

Hem N. Naik, Dilip Kanjariya, Shahnaz Parveen, Abha Meena, Iqrar Ahmad, Harun Patel, Ramavatar Meena, Smita Jauhari

Summary: Different plant extracts from Dalbergia sissoo bark, root, and branch showed antioxidant and anticancer effects on various cancer cell lines. The bark extract had the strongest antioxidant activity and effectively inhibited the growth of A431, A549, and NCIH 460 cancer cells. Molecular docking and dynamic simulation studies indicated that Prunetin, Tectorigenin, and Prunetin 4'-O-Galactoside have strong binding affinity to the EGFR binding domain. These findings suggest that these compounds may have potential as antioxidant and anticancer agents in the pharmaceutical industry.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Biochemistry & Molecular Biology

Myricetin 3-rhamnoside retards the proliferation of hormone-independent breast cancer cells by targeting hyaluronidase

Shilpi Singh, Akhilesh Kumar Maurya, Abha Meena, Nidhi Mishra, Suaib Luqman

Summary: Myricetin 3-rhamnoside exhibits antiproliferative activity and regulates poor prognostic markers in breast cancer cell lines. The findings suggest that Myricetin 3-rhamnoside could serve as a pharmacophore for designing and synthesizing novel agents to manage hormone-independent breast cancer.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Biochemistry & Molecular Biology

Exploration of selected monoterpenes as potential TRPC channel family modulator in lung cancer, an in-silico upshot

Akanksha Singh, Anamika Mishra, Abha Meena, Nidhi Mishra, Suaib Luqman

Summary: Lung cancer is a major cause of cancer-related death, with nearly two million cases annually. In order to effectively treat this multifactorial disease, it is necessary to develop novel molecular therapies that can target multiple related cellular processes simultaneously. Ion channels, particularly the transient receptor potential canonical (TRPC) channel family, have been implicated in lung cancer, and phytochemicals, such as monoterpenes, have shown health benefits in cancer treatment. Through molecular docking analysis, thymoquinone was found to have a high binding potential with the TRPC4 channel and exhibited stability during interaction. In-silico evaluations also showed that thymoquinone is a druggable candidate with minimal toxicity. Further investigation and optimization of thymoquinone as a potential drug for lung cancer treatment is recommended.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Chemistry, Medicinal

Escin enhanced the efficacy of sorafenib by autophagy-mediated apoptosis in lung cancer cells

Yusuf Hussain, Jyoti Singh, Abha Meena, Rohit Anthony Sinha, Suaib Luqman

Summary: This study explores the therapeutic potential of combining escin with sorafenib and finds that the combination treatment can significantly reduce the effective dose of sorafenib and inhibit autophagy in lung cancer cells, inducing late apoptosis.

PHYTOTHERAPY RESEARCH (2023)

Review Chemistry, Medicinal

Monoterpenoids: An upcoming class of therapeutic agents for modulating cancer metastasis

Anurag Mathur, Abha Meena, Suaib Luqman

Summary: Monoterpenoids, a subclass of terpenoids, have been extensively studied for their antitumor properties, including antiproliferative, apoptotic, antiangiogenic, and antimetastatic effects. This review focuses on the effects of specific monoterpenoids on metastasis and relevant signaling pathways. Monoterpenoids exhibit complexity as natural products that regulate metastatic proteins through various signaling pathways. However, limited clinical trials hinder the drug usage of monoterpenoids in preventing cancer metastasis.

PHYTOTHERAPY RESEARCH (2023)

暂无数据